The Clinical Experiences of "New Duromedics Valve" Replacement.
- Author:
Meyun Shick KANG
1
;
Kyung Jong YOO
;
Chee Soon YOON
;
Han Ky PARK
Author Information
1. Division of Cardiovascular Surgery, Cardiovascular Center Cardiovascular Research Center, Yonsei University College of Medicine, Korea.
- Publication Type:Original Article
- Keywords:
Heart valve prosthesis;
Heart valve replacement
- MeSH:
Adult;
Endocarditis;
Follow-Up Studies;
Freedom;
Heart;
Heart Valve Prosthesis;
Hemolysis;
Hemorrhage;
Humans;
International Normalized Ratio;
Mortality;
Postoperative Complications;
Survival Rate;
Thromboembolism;
Thrombosis
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
1997;30(10):979-985
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Between October 1991 and May 1995, 256 "New Duromedics Valve"(Edward TEKNA Bileaflet Valve) were implanted in 208 adult patients(171 mitral, 82 aortic and 3 tricuspid) with age ranging from 18 years to 70 years(mean 48.2+/-11.6 years). Postoperative complication rates were 12.2%, but there was none valve related one. Overall early mortality rate were 1.4%(1.6% for MVR, 2.1% for DVR, and none for AVR or TVR) respectively. Follow-up was 99% completed ranging in duration from 2 months to 46 months. There were 6 valve-related late complications(2.9%) with 2 patients with upper gastrointestinal bleeding, 2 with cerebral thromboembolism, 1 with valve thrombosis and 1 with valve endocarditis. Freedom from these valve-related major complications were 89.9% at 40 months. There were 5 late deaths(2.4%). one of these late deaths was considered valve-related. Overall actuarial survival rates at 40 months were 95.5%, 96.8% for mitral, 97.1% for aortic, 100% for tricuspid, and 92.0% for double valve replacement respectively. Preoperative New York Heart Association functional class were 2.9, and 1.3 in post-operative state. We have been trying to keep the international normalized ratio(INR) with range of 2.5 to 3.0. The INR of 4 patients of 5 with anticoagulant ralated complications was beyond the range. To reduce the rate of anticoagulant related complications, we felt very strongly that the INR should be kept between 2.5 and 3.0. In our cases, there was no structural failure or significant hemolysis in the absence of periprosthetic leak. This experience encourages us to continue using the "New Duromedics Valve".
